Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
43°
Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about TVTX
Recent news which mentions TVTX
< Previous
1
2
3
4
5
Next >
What 10 Analyst Ratings Have To Say About Travere Therapeutics
February 22, 2023
Tickers
TVTX
Tags
Analyst Ratings
Benzinga
Market News
From
Benzinga
Why CVRx Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
February 21, 2023
Tickers
AKAN
ALRN
AMAM
APLS
Tags
OWLT
UFAB
Market News
From
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 21, 2023
Tickers
ALRN
AMAM
CMMB
CVRX
Tags
SRNE
CVRX
Market News
From
Benzinga
Manitowoc, Helix Energy Solutions, JELD-WEN Holding And Other Big Stocks Moving Higher On Tuesday
February 21, 2023
Tickers
APLS
AY
DDL
HLX
Tags
Movers
TVTX
APLS
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 21, 2023
February 21, 2023
Tickers
AEL
ALNY
AN
ATNM
Tags
PB
MAIA
DOCU
From
Benzinga
Travere Therapeutics Scores Accelerated FDA Approval For Rare Kidney Disease Treatment
February 21, 2023
Tickers
CSLLY
LGND
TVTX
Tags
Trading Ideas
FDA
Benzinga
From
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
February 20, 2023
Tickers
AKTX
APGN
APLT
BACK
Tags
BACK
APLT
MHUA
From
Benzinga
The Nasdaq Is Rebounding: 2 Supercharged Growth Stocks to Buy in February
February 01, 2023
Tickers
RETA
TVTX
Tags
Market News
Recent Press Releases
TVTX
From
Motley Fool
February PDUFA Catalysts Biotech Investors Must Know: Sanofi's Bleeding Disorder Drug, Regeneron's Twin Eylea Label Expansions, 3 Delayed Approvals And More
January 31, 2023
Tickers
APLS
BIIB
CYTK
EBS
Tags
Biotech
EBS
FDA
From
Benzinga
The Latest Analyst Ratings for Travere Therapeutics
January 30, 2023
Tickers
TVTX
Tags
BZI/AAR
Market News
Benzinga
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
December 14, 2022
Tickers
ABCM
ACRS
ADM
AGRO
Tags
RPM
Benzinga
ACRS
From
Benzinga
Stocks That Hit 52-Week Lows On Monday
December 12, 2022
Tickers
NVFY
OCUL
ONDS
OPK
Tags
SBET
TMPO
TVTX
From
Benzinga
4 Analysts Have This to Say About Travere Therapeutics
December 05, 2022
Tickers
TVTX
Tags
BZI/AAR
Market News
Benzinga
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 5, 2022
December 05, 2022
Tickers
AKTX
ALGT
ALK
AOMR
Tags
SR
CADE
Analyst Ratings
From
Benzinga
Where Travere Therapeutics Stands With Analysts
December 05, 2022
Tickers
TVTX
Tags
TVTX
Benzinga
Analyst Ratings
From
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
November 22, 2022
Tickers
SONN
SOUN
STOK
STRC
Tags
VYNT
TSP
BZI/ftw
From
Benzinga
Travere Therapeutics Earnings Perspective: Return On Capital Employed
November 03, 2022
Tickers
TVTX
Tags
Benzinga
Earnings
Market News
From
Benzinga
Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know
November 01, 2022
Tickers
APLS
ARDX
AZN
FOLD
Tags
APLS
AZN
News
From
Benzinga
Recap: Travere Therapeutics Q3 Earnings
October 27, 2022
Tickers
TVTX
Tags
TVTX
BZI/Recaps
Benzinga
From
Benzinga
Earnings Scheduled For October 27, 2022
October 27, 2022
Tickers
OIS
ONTO
OPCH
OPI
Tags
UVE
OSK
SHYF
From
Benzinga
Earnings Outlook For Travere Therapeutics
October 26, 2022
Tickers
TVTX
Tags
Earnings
Benzinga
Market News
From
Benzinga
Analyst Cuts Price On Travere Therapeutics Citing Expected Delayed PDUFA
October 14, 2022
Tickers
TVTX
Tags
Market News
Movers
Briefs
From
Benzinga
121 Stocks That Hit Their 52-Week Low
October 14, 2022
Tickers
ACHV
ACST
AMBP
ANGI
Tags
PGY
MEDS
MOBBW
From
Benzinga
Expert Ratings for Travere Therapeutics
October 14, 2022
Tickers
TVTX
Tags
Benzinga
Analyst Ratings
BZI/AAR
From
Benzinga
FDA Requests For Additional Monitoring For Travere Therapeutics' Sparsentan In Rare Kidney Disease
October 14, 2022
Tickers
TVTX
Tags
Biotech
Trading Ideas
FDA
From
Benzinga
Insider Buying 2022: 15 Stocks to Bet On Despite the Bear Market
October 05, 2022
Tickers
BTTX
FSTR
HPK
LAZY
Tags
BTC/USD
TELA
LRMR
From
InvestorPlace
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
August 22, 2022
Tickers
BLTE
BNTX
CUE
GERN
Tags
PODD
News
Small Cap
From
Benzinga
Travere, CSL's Sparsentan Application Is Under European Review For Rare Kidney Disorder
August 22, 2022
Tickers
CSLLY
TVTX
Tags
Biotech
News
Small Cap
From
Benzinga
Travere Therapeutics Return On Capital Employed Overview
August 15, 2022
Tickers
TVTX
Tags
TVTX
Market News
BZI/ROCE
From
Benzinga
H.C. Wainwright reduces Travere Therapeutics (TVTX) PT’s price to $42
August 09, 2022
Tickers
TVTX
Tags
Analyst Rating
News
TVTX
From
Best Stocks
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.